Equipotent antihypertensive agents variously affect pulsatile hemodynamics and regression of cardiac hypertrophy in spontaneously hypertensive rats

Circulation

Volumn 94, Issue 11, 1996, Pages 2923-2929

  Mitchell, Gary F ^a   Pfeffer, Marc A ^a   Finn, Peter V ^a   Pfeffer, Janice M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Aorta; Fourier analysis; hypertension; hypertrophy; ventricles

Indexed keywords

ANTIHYPERTENSIVE AGENT; ZOFENOPRIL;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; ENZYME INHIBITION; HEART HYPERTROPHY; HEMODYNAMIC MONITORING; HYPERTENSION; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; PULSATILE FLOW; RAT; REGRESSION ANALYSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR RESISTANCE;

EID: 0029800411     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.11.2923     Document Type: Article

References (53)

1. Kannel WB, Castelli WP, McNamara PM, McKee PA, Feinleib M. Role of blood pressure in the development of congestive heart failure: the Framingham Study. N Engl J Med. 1972;287:781-787.
2. Kannel WB. Prevalence and natural history of electrocardiographic left ventricular hypertrophy. Am J Med. 1983;75:4-11.
3. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;322:1561-1566.
4. Casale PN, Devereux RB, Milner M, Zullo G, Harshfield GA, Pickering TG, Laragn JH. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med. 1986;105:173-178.
5. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 1991;114:345-352.
6. Pfeffer MA, Pfeffer JM. Pharmacologic regression of cardiac hypertrophy in experimental hypertension. J Cardiovasc Pharmacol. 1984;6:S865-S869.
7. Devereux RB. Hypertensive cardiac hypertrophy: pathophysiologic and clinical characteristics. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis, and Management. New York, NY: Raven Press; 1989:359-377.
8. Sen S, Tarazi RC, Bumpus FM. Cardiac hypertrophy and antihypertensive therapy. Cardiovasc Res. 1977;11:427-433.
9. Dzau VJ, Safar MD. Large conduit arteries in hypertension: role of the vascular renin-angiotensin system. Circulation. 1988;77:947-954.
10. Devereux RB, Pickering TG, Cody RJ, Laragh JH. Relation of renin-angiotensin system activity to left ventricular hypertrophy and function in experimental and human hypertension. J Clin Hypertens. 1987;3:87-103.
11. Morgan HE, Baker KM. Cardiac hypertrophy: mechanical, neural, and endocrine dependence. Circulation. 1991;83:13-25.
12. Ganau A, Devereux RB, Roman MJ, De Simone G, Pickering TG, Saba PS, Vargiu P, Simongini I, Laragh JH. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol. 1992;19:1550-1558.
13. Ganau A, Devereux RB, Pickering TG, Roman MJ, Schnall PL, Santucci S, Spitzer MC, Laragh JH. Relation of left ventricular hemodynamic load and contractile performance to left ventricular mass in hypertension. Circulation. 1990;81:25-36.
14. Saba PS, Roman MJ, Pini R, Spitzer M, Ganau A, Devereux RB. Relation of arterial pressure waveform to left ventricular and carotid anatomy in normotensive subjects. J Am Coll Cardiol. 1993;22:1873-1880.
15. Milnor WR. Pulsatile blood flow. N Engl J Med. 1972;287:27-34.
16. Pfeffer JM, Pfeffer MA, Fletcher PJ, Fishbein MC, Braunwald E. Favorable effects of therapy on cardiac performance in spontaneously hypertensive rats. Am J Physiol. 1982;242:H776-H784.
17. Pfeffer JM, Pfeffer MA, Mirsky I, Braunwald E. Regression of left ventricular hypertrophy and prevention of ventricular dysfunction by captopril in the spontaneously hypertensive rat. Proc Natl Acad Sci U S A. 1982;79:3310-3314.
18. Mitchell GF, Pfeffer MA, Westerhof N, Pfeffer JM. Measurement of aortic input impedance in the rat. Am J Physiol. 1994;267:H1907-H1915.
19. Fletcher PJ, Pfeffer JM, Pfeffer MA, Braunwald E. Left ventricular diastolic pressure-volume relations in rats with healed myocardial infarction: effects on systolic function. Circ Res. 1981;49:618-626.
20. De Simone G, Devereux RB, Camargo MJF, Volpe M, Wallerson DC, Atlas SA, Laragh JH. In vivo left ventricular anatomy in rats with two-kidney, one clip and one-kidney, one clip renovascular hypertension. J Hypertens. 1992;10:725-732.
21. Zuckerman BD, Yin FCP. Aortic impedance and compliance in hypertensive rats. Am J Physiol. 1989;257:H553-H562.
22. Laxminarayan S, Sipkema P, Westerhof N. Characterization of the arterial system in the time domain. IEEE Trans Biomed Eng. 1978;BME-25:177-184.
23. Sipkema P, Westerhof N, Randall OS. The arterial system characterized in the time domain. Cardiovasc Res. 1980;14:270-279.
24. Newman DL, Sipkema P, Greenwald SE, Westerhof N. High frequency characteristics of the arterial system. J Biomech. 1986;19:817-824.
25. Liu Z, Brin KP, Yin FCP. Estimation of total arterial compliance: an improved method and evaluation of current methods. Am J Physiol. 1986;251:H588-H600.
26. Mirsky I, Pfeffer JM, Pfeffer MA, Braunwald E. The contractile state as the major determinant in the evolution of left ventricular dysfunction in the spontaneously hypertensive rat. Circ Res. 1983;53:767-778.
27. Grossman W. Cardiac hypertrophy: useful adaptation or pathologic process? Am J Med. 1980;69:576-584.
28. Kelly R, Hayward C, Avolio A, O'Rourke M. Noninvasive determination of age-related changes in the human arterial pulse. Circulation. 1989;80:1652-1659.
29. Suga H, Kitabatake A, Sagawa K. End-systolic pressure determines stroke volume from fixed end-diastolic volume in the isolated canine left ventricle under a constant contractile state. Circ Res. 1979;44:238-249.
30. Isnard RN, Pannier BM, Laurent S, London GM, Diebold B, Safar ME. Pulsatile diameter and elastic modulus of the aortic arch in essential hypertension: a noninvasive study. J Am Coll Cardiol. 1989;13:399-405.
31. Girerd Z, Laurent S, Pannier B, Asmar R, Safar ME. Arterial distenstbility and left ventricular hypertrophy in patients with sustained essential hypertension. Am Heart J. 1991;122:1210-1214.
32. Merillon JP, Motte G, Masquet C, Azancot I, Guiomard A, Gourgon R. Relationship between physical properties of the arterial system and left ventricular performance in the course of aging and arterial hypertension. Eur Heart J. 1982;3:95-102.
33. Levy BI, Babalis D, Lacolley P, Poitevin P, Safar ME. Cardiac hypertrophy and characteristic impedance in spontaneously hypertensive rats. J Hypertens. 1988;6:S110-S111.
34. Pannier B, Brunel P, El Aroussy W, Lacolley P, Safar ME. Pulse pressure and echocardiographic findings in essential hypertension. J Hypertens. 1989;7:127-132.
35. Bouthier JD, De Luca N, Safar ME, Simon AC. Cardiac hypertrophy and arterial distensibility in essential hypertension. Am Heart J. 1985;109:1345-1352.
36. Morita S, Asou T, Juboyama I, Tokunaga K, Harasawa Y, Sunagawa K. Increased characteristic impedance causes left ventricular hypertrophy in dogs. Circulation. 1989;80:299. Abstract.
37. Maeta H, Hori M. Effect of a lack of aortic 'windkessel' properties on the left ventricle. Jpn Circ J. 1985;49:232-237.
38. Wolinsky H. Long-term effects of hypertension on the rat aortic wall and their relation to concurrent aging changes. Circ Res. 1912;30:301-309.
39. O'Rourke M. Arterial stiffness, systolic blood pressure, and logical treatment of hypertension. Hypertension. 1990;15:339-347.
40. Nichols WW, O'Rourke MF, Avolio AP, Yaginuma T, Murgo JP, Pepine CJ, Conti CR. Effects of age on ventricular-vascular coupling. Am J Cardiol. 1985;55:1179-1184.
41. Nichols WW, O'Rourke MF, Avolio AP, Yaginuma T, Pepine CJ, Conti CR. Ventricular/vascular interaction in patients with mild systemic hypertension and normal peripheral resistance. Circulation. 1986;74:455-462.
42. Westerhof N, O'Rourke MF. Haemodynamic basis for the development of left ventricular failure in systolic hypertension and for its logical therapy. J Hypertens. 1995;13:943-952.
43. Owens GK. Influence of blood pressure on development of aortic medial smooth muscle hypertrophy in spontaneously hypertensive rats. Hypertension. 1987;9:178-187.
44. Albaladejo P, Bouaziz H, Duriez M, Gohlke P, Levy B, Safar ME, Benetos A. Angiotensin converting enzyme inhibition prevents the increase in aortic collagen in rats. Hypertension. 1994;23:74-82.
45. Tsoporis J, Leenen FH. Effects of arterial vasodilators on cardiac hypertrophy and sympathetic activity in rats. Hypertension. 1988;11:376-386.
46. Stone DN, Dujardin JL. Changes in smooth muscle tone influence characteristic impedance of the aorta. Am J Physiol. 1984;246:H1-H7.
47. Simon AC, Safar ME, Levenson JA, Bouthier JE, Benetos A. Action of vasodilation drugs on small and large arteries of hypertensive patients. J Cardiovasc Pharmacol. 1983;5:626-631.
48. Cody RJ, Binkley PF, Haas GJ, Brown DM. Acute myocardial and vascular responses to specific angiotensin II antagonism in the spontaneously hypertensive rat. Am J Hypertens. 1995;8:500-508.
49. Binkley PF, Van Fossen DB, Haas GJ, Cody RJ, Leier CV. Persistence of abnormal ventriculoarterial coupling and decreased conduit vessel compliance despite peripheral vasodilation with hydralazine and nitroglycerin in congestive heart failure. J Am Coll Cardiol. 1994;23:382A. Abstract.
50. Gohlke P, Lamberty V, Kuwer I, Bartenbach S, Schnell A, Unger T. Vascular remodeling in systemic hypertension. Am J Cardiol. 1993;71:2E-7E.
51. Clozel M, Kuhn H, Hefti F. Effects of angiotensin converting enzyme inhibitors and of hydralazine on endothelial function in hypertensive rats. Hypertension. 1990;16:532-540.
52. Friberg P, Folkow B, Nordlander M. Cardiac dimensions in spontaneously hypertensive rats following different modes of blood pressure reduction by antihypertensive treatment. J Hypertens. 1986;4:85-92.
53. Leenen FHH, Tsoporis J. Cardiac volume load as a determinant of the response of cardiac mass to antihypertensive therapy. Ear Heart J. 1990;11:100-106.